Sign in
4

Changes in Ownership

Vir Biotechnology, Inc. Filed Acc 0001628280-26-012393

EVP, General Counsel, Corp Sec sold 16,817 shares at an average $9.77 ($164,247)

  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
de Verneuil Vanina EVP, General Counsel, Corp Sec 2026-02-24 Sale 10b5-1 −3,117 $9.53 $29,713 126,682 D
de Verneuil Vanina EVP, General Counsel, Corp Sec 2026-02-25 Sale 10b5-1 −13,700 $9.82 $134,534 112,982 D
Open-market sales · 16,817 sh · avg $9.77 · $164,247
Loading xslF345X05/wk-form4_1772142894.xml…